candesartan has been researched along with Alcoholic Cirrhosis in 1 studies
candesartan: a nonpeptide angiotensin II receptor antagonist
candesartan : A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, MY | 1 |
| Cho, MY | 1 |
| Baik, SK | 1 |
| Jeong, PH | 1 |
| Suk, KT | 1 |
| Jang, YO | 1 |
| Yea, CJ | 1 |
| Kim, JW | 1 |
| Kim, HS | 1 |
| Kwon, SO | 1 |
| Yoo, BS | 1 |
| Kim, JY | 1 |
| Eom, MS | 1 |
| Cha, SH | 1 |
| Chang, SJ | 1 |
1 trial available for candesartan and Alcoholic Cirrhosis
| Article | Year |
|---|---|
Beneficial effects of candesartan, an angiotensin-blocking agent, on compensated alcoholic liver fibrosis - a randomized open-label controlled study.
Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Biomarkers; Biopsy; Biphenyl C | 2012 |